Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.

@article{Halderman2018MedicalTO,
  title={Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.},
  author={Ashleigh A Halderman and Matthew W. Ryan and Christopher Clark and Raj Sindwani and Douglas D. Reh and David M. Poetker and Rosangela Invernizzi and Bradley F. Marple},
  journal={International forum of allergy & rhinology},
  year={2018},
  volume={8 6},
  pages={
          713-728
        }
}
BACKGROUND Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant hereditary disorder resulting in vascular dysplasia and formation of arteriovenous malformations. Recurrent epistaxis is a hallmark of the disease. An array of medical therapies are used in this patient population, but robust evidence-based recommendations regarding the medical treatment of epistaxis are lacking. This systematic review was performed to look at the current literature and make meaningful evidence… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-6 OF 6 CITATIONS

Clinical Practice Guideline: Nosebleed (Epistaxis)

  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2020
VIEW 6 EXCERPTS
CITES BACKGROUND

Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary

  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2020
VIEW 1 EXCERPT
CITES BACKGROUND

Plain Language Summary: Nosebleed (Epistaxis)

  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2020
VIEW 1 EXCERPT
CITES BACKGROUND